Charles Schwab’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,612
| Closed | -$17.3K | – | 3565 |
|
|
2023
Q4 | $17.3K | Hold |
1,612
| – | – | ﹤0.01% | 3496 |
|
|
2023
Q3 | $9.78K | Hold |
1,612
| – | – | ﹤0.01% | 3564 |
|
|
2023
Q2 | $11.1K | Hold |
1,612
| – | – | ﹤0.01% | 3591 |
|
|
2023
Q1 | $25.3K | Hold |
1,612
| – | – | ﹤0.01% | 3478 |
|
|
2022
Q4 | $32.2K | Hold |
1,612
| – | – | ﹤0.01% | 3443 |
|
|
2022
Q3 | $29K | Hold |
1,612
| – | – | ﹤0.01% | 3444 |
|
|
2022
Q2 | $36K | Sell |
1,612
-3,079
| -66% | -$68.8K | ﹤0.01% | 3440 |
|
|
2022
Q1 | $131K | Sell |
4,691
-793
| -14% | -$22.1K | ﹤0.01% | 3373 |
|
|
2021
Q4 | $249K | Hold |
5,484
| – | – | ﹤0.01% | 3325 |
|
|
2021
Q3 | $458K | Hold |
5,484
| – | – | ﹤0.01% | 3173 |
|
|
2021
Q2 | $521K | Buy |
5,484
+4,691
| +592% | +$446K | ﹤0.01% | 3159 |
|
|
2021
Q1 | $132K | Buy |
+793
| New | +$132K | ﹤0.01% | 3358 |
|
|
2019
Q2 | – | Sell |
-75
| Closed | -$13K | – | 3277 |
|
|
2019
Q1 | $13K | Hold |
75
| – | – | ﹤0.01% | 3189 |
|
|
2018
Q4 | $9K | Sell |
75
-23
| -23% | -$2.76K | ﹤0.01% | 3144 |
|
|
2018
Q3 | $22K | Buy |
+98
| New | +$22K | ﹤0.01% | 3130 |
|
|
2016
Q3 | – | Sell |
-11
| Closed | -$9K | – | 3051 |
|
|
2016
Q2 | $9K | Hold |
11
| – | – | ﹤0.01% | 3098 |
|
|
2016
Q1 | $8K | Hold |
11
| – | – | ﹤0.01% | 3055 |
|
|
2015
Q4 | $12K | Hold |
11
| – | – | ﹤0.01% | 3093 |
|
|
2015
Q3 | $13K | Hold |
11
| – | – | ﹤0.01% | 3086 |
|
|
2015
Q2 | $24K | Hold |
11
| – | – | ﹤0.01% | 3082 |
|
|
2015
Q1 | $11K | Hold |
11
| – | – | ﹤0.01% | 3078 |
|
|
2014
Q4 | $12K | Hold |
11
| – | – | ﹤0.01% | 3103 |
|
|
2014
Q3 | $12K | Hold |
11
| – | – | ﹤0.01% | 3069 |
|
|
2014
Q2 | $22K | Sell |
11
-85
| -89% | -$170K | ﹤0.01% | 3081 |
|
|
2014
Q1 | $206K | Hold |
96
| – | – | ﹤0.01% | 2935 |
|
|
2013
Q4 | $222K | Buy |
96
+56
| +140% | +$130K | ﹤0.01% | 2926 |
|
|
2013
Q3 | $106K | Sell |
40
-12
| -23% | -$31.8K | ﹤0.01% | 3028 |
|
|
2013
Q2 | $479K | Buy |
+52
| New | +$479K | ﹤0.01% | 2542 |
|